by mokosam on November 10, 2009
A group of drunken fruit flies have helped researchers from North Carolina State and Boston universities identify entire networks of genes — also present in humans — that play a key role in alcohol drinking behavior.
This discovery, published in the October 2009 print issue of the journal Genetics, provides a crucial explanation of why some [...]
by mokosam on December 23, 2008
Prozac is regularly prescribed to ease the emotional pain of patients who are being treated for cancer. But can this common anti-depressant help to fight cancer itself?
Dr. Dan Peer of the Department of Cell Research and Immunology at Tel Aviv University is proving that it can. A study he and his colleagues recently completed validates [...]
by mokosam on December 18, 2008
Malaria, one of the oldest diseases known to man, has shown no signs of slowing down as it ages. More than 1 million children die from malaria in sub-Saharan Africa each year, and in areas along the Thailand/Cambodian border multiple drug-resistant strains of the disease are becoming commonplace.
With the previously mainstay antimalarial drug chloroquine nearly [...]
by mokosam on December 18, 2008
Pregnancy and surgery patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting protein. Results from a study by researchers at Yale School of Medicine and other institutions were presented December 6 at the Annual Meeting of the American Society of Hematology (ASH) in San Francisco.
The [...]
by mokosam on December 18, 2008
Hundreds of millions of people, mainly in developing countries, are disabled by infectious diseases, according to the World Health Organization.
More than 12 million people in 88 countries are infected with leishmaniasis, a parasitic disease spread by the bite of infected sand flies. Nearly 2 million new cases are reported and about 70,000 people die from [...]
by mokosam on December 18, 2008
Dr. Francois Bolduc keeps more than 300,000 fruit flies in a basement laboratory, where he manipulates their genes and then tests their mental abilities. He`s called the "fly guy," and he may sound like a comic book villain, but Bolduc is no mad scientist.
A new recruit to the University of Alberta`s Faculty of Medicine & [...]
by mokosam on December 16, 2008
The antidiabetes drug rosiglitazone may have the potential to protect kidney function in patients with a condition called focal segmental glomerulosclerosis (FSGS), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The phase I clinical findings indicate that the drug warrants further study in [...]
by mokosam on December 16, 2008
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
The oral drug, called CYT387, was tested in mice as well as in human cells. In both cases, it blocked the growth of certain bone marrow cancers called myeloproliferative disorders, also [...]
by mokosam on December 13, 2008
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
PROPEL (Pralatrexate in patients with Relapsed Or refractory PEripheral T-cell Lymphoma) findings were presented by the [...]